Cargando…
Advances in ovarian cancer treatment using a combination of statins with other drugs
New anti-cancer drugs are constantly being developed, especially targeted drugs. Although these drugs have achieved significant clinical efficacy, they do not play a significant role in ovarian cancer. Moreover, the research cycle and costs of such drugs are often huge. The repositioning of conventi...
Autores principales: | Xia, Lei, Ding, Shichao, Wang, Xuezhen, Zhang, Xiaoyu, Zhu, Lin, Zhang, Hairong, Li, Huirong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9845598/ https://www.ncbi.nlm.nih.gov/pubmed/36686716 http://dx.doi.org/10.3389/fphar.2022.1048484 |
Ejemplares similares
-
The Role of Succinic Acid Metabolism in Ovarian Cancer
por: Xia, Lei, et al.
Publicado: (2021) -
Advances in Stigmasterol on its anti-tumor effect and mechanism of action
por: Zhang, Xiaoyu, et al.
Publicado: (2022) -
Ligustrazine inhibits the proliferation and migration of ovarian cancer cells via regulating miR-211
por: Zhang, Hairong, et al.
Publicado: (2021) -
New Hypoglycemic Drugs: Combination Drugs and Targets Discovery
por: Ni, Xiayun, et al.
Publicado: (2022) -
In Vitro Activity of Peptide Antibiotics in Combination With Other Antimicrobials on Extensively Drug-Resistant Acinetobacter baumannii in the Planktonic and Biofilm Cell
por: Meng, Qianlin, et al.
Publicado: (2022)